Protocol Ledger

NCT03364491 · Phase III · COMPLETED

Tranexamic Acid for the Prevention of Obstetrical Hemorrhage After Cesarean

Interventional Phase III clinical trial protocol NCT03364491 sponsored by The George Washington University Biostatistics Center in Rare Genetic, Women's Health, and Other, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2018-03-15 Enrollment: 11,000 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT03364491
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)11,000 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT03364491
Protocol FieldVerified Registry Value
NCT IdentifierNCT03364491
Consolidated Lead SponsorThe George Washington University Biostatistics Center
Therapeutic Condition CohortRare Genetic, Women's Health, and Other
Clinical Trial PhasePhase III
Overall Recruitment StatusCOMPLETED
Registered Enrollment11,000 participants (ACTUAL)
Registered Start Date2018-03-15
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Rare Genetic, Women's Health, and Other Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI